Eric DeJesus Joins Georgia Life Sciences in Washington for CSBA Fly-In

Annate Bitherapeutics is proud to share that Eric DeJesus, PhD, co-founder and CEO of Annate Bitherapeutics, joined Georgia Life Sciences in Washington, DC for the Council of State Bioscience Associations (CSBA) Fly-In.

Georgia Life Sciences CEO Maria Thacker Goethe represented Georgia alongside Evan Scullin, MD, founder of LumeniSci, and Eric DeJesus, PhD, co-founder and CEO of Annate Bitherapeutics.

During the visit, the group met with the offices of Rep. Rick Allen, Rep. Buddy Carter, Rep. Mike Collins, Rep. Richard McCormick, Rep. Lucy McBath, Sen. Jon Ossoff, and Sen. Raphael Warnock to discuss the importance of biotechnology to Georgia’s economy, patients, and future.

According to Georgia Life Sciences, the delegation thanked Congress for reauthorizing SBIR/STTR and emphasized the importance of strong NIH funding, timely grantmaking, predictable policy, a modernized FDA, continued U.S. leadership in biotech, support for the Congressional Biotech Caucus, and biotechnology’s growing importance to national security.

Reflecting on the experience, Dr. DeJesus said, “I learned so many wonderful lessons and left feeling significantly more confident about the direction our state is headed for the future of biotech!”

Annate is grateful to Georgia Life Sciences for its leadership in advocating for the life sciences community and for the opportunity to help represent Georgia’s biotech sector in these important conversations.

Read more: Georgia Life Sciences on LinkedIn